Vance Street Capital, a Los Angeles-based middle-market private equity firm, has named J. Mark King as an operating partner. The appointment is effective immediately.
Most recently, King was president and CEO of Tegra Medical. Prior to Tegra, King was president and CEO of Clinical Innovations. In addition to Tegra Medical and Clinical Innovations, King has held senior positions at Baxter Healthcare, Cardinal Health and Johnson and Johnson.
Vance invests in highly engineered solutions businesses across the medical, life science, industrial, aerospace and defense sectors.